News & Views

Pre-eclampsia: Screening and aspirin therapy for prevention of pre-eclampsia

Aspirin therapy for the prevention of pre-eclampsia in unselected women is minimally effective. New data suggest that use of a screening strategy based on clinical, biochemical and biophysical factors to identify those at high risk of pre-term pre-eclampsia could improve the efficacy of preventive aspirin therapy.

  • Subscribe to Nature Reviews Nephrology for full access:



Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.


  1. 1.

    , , , & Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369, 1791–1798 (2007).

  2. 2.

    et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N. Engl. J. Med. 377, 613–622 (2017).

  3. 3.

    , , , & Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn. Ther. 33, 8–15 (2013).

  4. 4.

    et al. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet. Gynecol. 41, 491–499 (2013).

  5. 5.

    et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am. J. Obstet. Gynecol. 216, 110–120.e6 (2017).

  6. 6.

    et al. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol. Int. 30, 260–279 (2013).

  7. 7.

    U.S. Preventive Services Task Force et al. Screening for preeclampsia: US Preventive Services Task Force Recommendation Statement. JAMA 317, 1661–1667 (2017).

  8. 8.

    et al. A cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States. Obstet. Gynecol. 126, 1242–1250 (2015).

  9. 9.

    & If we know so much about preeclampsia, why haven't we cured the disease? J. Reprod. Immunol. 99, 1–9 (2013).

Download references

Author information


  1. Magee Womens Research Institute, Department of Obstetrics, Gynecology and Reproductive Sciences, 204 Craft Avenue, Pittsburgh, PA 15213, USA.

    • James M. Roberts
    •  & Katherine P. Himes


  1. Search for James M. Roberts in:

  2. Search for Katherine P. Himes in:

Competing interests

J.M.R. is a consultant for Metabolomics, which is in the early stages of developing a diagnostic for pre-eclampsia. K.P.H. declares no competing interests.

Corresponding author

Correspondence to James M. Roberts.